Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. Sep-Oct 1998;19(5):469-77.
doi: 10.1016/s0197-4580(98)00079-7.

Long-term Treatment With Calcitriol (1,25(OH)2 Vit D3) Retards a Biomarker of Hippocampal Aging in Rats

Affiliations

Long-term Treatment With Calcitriol (1,25(OH)2 Vit D3) Retards a Biomarker of Hippocampal Aging in Rats

P W Landfield et al. Neurobiol Aging. .

Abstract

Based on a literature implicating altered calcium homeostasis in brain aging and Alzheimer's Disease (AD) and evidence of decreased vitamin D action in AD subjects, the possibility was tested that calcitriol (1,25(OH)2 vitamin D3), the active form of vitamin D3, might reduce markers of brain aging in rats. Animals were treated 5x weekly for prolonged periods (6-12 months) with either calcitriol in doses sufficient to elevate serum calcium and phosphate (20 ng/rat), calcitonin (1.5 IU/rat) or vehicle, in three separate long-term experiments on aging rats. New stereological methods (physical disector) of cell counting were used to evaluate neuronal density, a reliable biomarker of hippocampal aging in rats. In two experiments utilizing Brown-Norway x F344 hybrid rats (BN x F344), 8 months and 12 months of chronic treatment with calcitriol resulted in a higher density of CA1 neurons in the middle regions of the hippocampus, compared to vehicle or calcitonin treatment. However, one study with aging F344 rats was terminated early because of extensive strain-specific pathology and no effect of calcitriol on neuronal density was observed. These studies suggest that, under some conditions, hormonal treatments that regulate calcium homeostasis can modulate markers of brain aging.

Similar articles

See all similar articles

Cited by 12 articles

See all "Cited by" articles

MeSH terms

Feedback